Matches in Nanopublications for { ?s ?p "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP295703.RAQ-o657nWou7-K4tQ7lSV9EZi-kW89dlQ5v5uimqhSio130_assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295703.RAQ-o657nWou7-K4tQ7lSV9EZi-kW89dlQ5v5uimqhSio130_provenance.
- NP295972.RAJy9xsv6DV-8GpfhuGVwR-qFaucK8ihOo_l9T8UPBQzY130_assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP295972.RAJy9xsv6DV-8GpfhuGVwR-qFaucK8ihOo_l9T8UPBQzY130_provenance.
- NP652972.RAFD1duZdc3hMeXi-IJeTpd4zZ-lk5GQXHDB3co8smCxE130_assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652972.RAFD1duZdc3hMeXi-IJeTpd4zZ-lk5GQXHDB3co8smCxE130_provenance.
- NP652978.RAy4jAfMK0czmP8_0Z_5rNAGzYoYH9mwoOgZzI8AipJNc130_assertion description "[To investigate the contribution of heparan sulfate proteoglycan and Ras/MEK/ERK to the overexpression of profibrotic proteins and the enhanced contractile ability of dermal fibroblasts from patients with systemic sclerosis (SSc; scleroderma).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP652978.RAy4jAfMK0czmP8_0Z_5rNAGzYoYH9mwoOgZzI8AipJNc130_provenance.